Puccio C - Search Results

1

Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer.

Mittelman A, Savona S, Puccio C, Chun H, Ahmed T, Feldman E, Sullivan P, Arnold P, Arlin Z. Mittelman A, et al. Among authors: puccio c. Invest New Drugs. 1990;8 Suppl 1:S65-7. doi: 10.1007/BF00171986. Invest New Drugs. 1990. PMID: 1696246

2

A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.

Puccio CA, Mittelman A, Lichtman SM, Silver RT, Budman DR, Ahmed T, Feldman EJ, Coleman M, Arnold PM, Arlin ZA, et al. Puccio CA, et al. J Clin Oncol. 1991 Sep;9(9):1562-9. doi: 10.1200/JCO.1991.9.9.1562. J Clin Oncol. 1991. PMID: 1714949 Clinical Trial.

3

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Lichtman SM, Mittelman A, Budman DR, Puccio CA, Chun HG, Allen SL, Ahmed T, Arlin ZA. Lichtman SM, et al. Among authors: puccio ca. Leuk Lymphoma. 1991;6(1):61-3. doi: 10.3109/10428199109064880. Leuk Lymphoma. 1991. PMID: 27457577

4

A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion.

Mittelman A, Puccio C, Gafney E, Coombe N, Singh B, Wood D, Nadler P, Ahmed T, Arlin Z. Mittelman A, et al. Among authors: puccio c. Invest New Drugs. 1992 Aug;10(3):183-90. doi: 10.1007/BF00877244. Invest New Drugs. 1992. PMID: 1428728 Clinical Trial.

5

Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.

Ahmed T, Cook P, Feldman E, Coombe N, Puccio C, Mittelman A, Chun H, Coleman M, Helson L. Ahmed T, et al. Among authors: puccio c. Leukemia. 1994 Apr;8(4):531-4. Leukemia. 1994. PMID: 8152247 Clinical Trial.

6

Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319).

Mittelman A, Chun HG, Puccio C, Coombe N, Lansen T, Ahmed T. Mittelman A, et al. Among authors: puccio c. Invest New Drugs. 1999;17(2):179-82. doi: 10.1023/a:1006379402114. Invest New Drugs. 1999. PMID: 10638489 Clinical Trial.

7

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy.

Arlin ZA, Ahmed T, Mittelman A, Cook P, Puccio CA, Helson L, Chun HG. Arlin ZA, et al. Among authors: puccio ca. Int J Clin Lab Res. 1992;21(4):273-7. doi: 10.1007/BF02591660. Int J Clin Lab Res. 1992. PMID: 1591379 Review.

8

Amsacrine is safe in patients with ventricular ectopy.

Puccio CA, Feldman EJ, Arlin ZA. Puccio CA, et al. Am J Hematol. 1988 Jul;28(3):197-8. doi: 10.1002/ajh.2830280315. Am J Hematol. 1988. PMID: 2457309

9

Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhage.

Feldman EJ, Arlin ZA, Ahmed T, Mittelman A, Ascensao JL, Puccio CA, Coombe N, Baskind P. Feldman EJ, et al. Among authors: puccio ca. Acta Haematol. 1989;82(3):117-21. doi: 10.1159/000205321. Acta Haematol. 1989. PMID: 2510432

10

Preliminary Experience with Short Course High-Dose Mitoxantrone in Combination with High-Dose Cytarabine in Patients with Acute Leukemia and Blastic Phase of Chronic Myelogenous Leukemia.

Feldman EJ, Biguzzi S, Ahmed T, Mittelman A, Puccio CA, Baskind P, Arlin ZA. Feldman EJ, et al. Among authors: puccio ca. Leuk Lymphoma. 1990;3(3):209-11. doi: 10.3109/10428199009050997. Leuk Lymphoma. 1990. PMID: 27457439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters